The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer.
Kai Conrad Cecil JohnsonDaniel GoldsteinJasmin TharakanDionisia QuirogaMahmoud KassemMichael GrimmAbdul MiahCraig VargoMichael BergerPreeti SudheendraAshley PariserMargaret E Gatti-MaysNicole WilliamsDaniel StoverSagar SardesaiRobert WesolowskiBhuvaneswari RamaswamyGary TozbikianPatrick M SchnellMathew Amprayil CherianPublished in: Oncology and therapy (2023)
Our findings demonstrate that dexamethasone has no clinically significant impact on pCR, RFS, or OS when given concurrently with NAC in patients with curative TNBC, regardless of diabetic status.